CRNX - Crinetics Pharmaceuticals, Inc.
39.51
-0.610 -1.544%
Share volume: 1,088,475
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$40.12
-0.61
-0.02%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.79%
Return on assets
-8.72%
Return on sales
0%
Return on invested capital
345.37%
Total debt ratio
8.07%
Debt ratio change over timeo
0%
Current Ratio
18.96%
Quick Ratio
0%
Cash Position Ratio
12.12%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.93%
Return on assets
-11.29%
Return on sales
0%
Return on invested capital
973.74%
Total debt ratio
9.59%
Debt ratio change over timeo
0%
Current Ratio
16.05%
Quick Ratio
0%
Cash Position Ratio
8.58%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.13%
Return on assets
-7.8%
Return on sales
0%
Return on invested capital
491.1%
Total debt ratio
6.61%
Debt ratio change over time
0%
Current Ratio
21.34%
Quick Ratio
0%
Cash Position Ratio
16.29%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRNX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -8.79% | 17.45% | 4.69% | -3.05% |
| Return on assets | -8.72% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 345.37% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 67% | 50% | 50% |
| Total debt ratio | 8.07% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 2% | 19% | 18% | 50% |
| Current Ratio | 16.05% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 8.58% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 21% | 28% | 28% |
| Short-term ratios | CRNX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -11.93% | 44.06% | 6.24% | -25.62% |
| Return on assets | -11.29% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 973.74% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 72% | 44% | 46% |
| Total debt ratio | 9.59% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 2% | 22% | 35% | 50% |
| Current Ratio | 16.05% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 8.58% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 14% | 16% | 33% |